Pipeline Blows: GSK, Medicines Co. Abandon Development of Drugs
GlaxoSmithKline (GSK) and Medicines Co. separately ended development of investigational drugs last week, with GSK pulling the plug on a complicated urinary tract infection (cUTI) treatment.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.